Deferred cytoreductive nephrectomy among patients with newly diagnosed metastatic renal cell carcinoma treated initially with sunitinib.

被引：0

作者：

Bhindi, Bimal

Graham, Jeffrey

Wells, Connor

Donskov, Frede

Pasini, Felice

Lee, Jae-Lyun

Basappa, Naveen S.

Hansen, Aaron Richard

Wood, Lori

Kollmannsberger, Christian K.

Kanesvaran, Ravindran

Yuasa, Takeshi

Ernst, D. Scott

Srinivas, Sandy

Rini, Brian I.

Bowman, I. Alex

Pal, Sumanta K.

Choueiri, Toni K.

Heng, Daniel Yick Chin

机构：

[1] Univ Calgary, Calgary, AB, Canada

[2] Univ Manitoba, Winnipeg, MB, Canada

[3] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada

[4] Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark

[5] S Maria della Misericordia Hosp, Dept Oncol, ULSS 18, Rovigo, Italy

[6] Asan Med Ctr, Seoul, South Korea

[7] Univ Ulsan, Coll Med, Seoul, South Korea

[8] Cleveland Clin, Cleveland, OH 44106 USA

[9] Princess Margaret Canc Ctr, Toronto, ON, Canada

[10] Dalhousie Univ, Halifax, NS, Canada

[11] BC Canc Vancouver Canc Ctr, Vancouver, BC, Canada

[12] Natl Canc Ctr Singapore, Singapore, Singapore

[13] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan

[14] London Hlth Sci Ctr, London Reg Canc Program, Dept Oncol, Div Med Oncol, London, ON, Canada

[15] Univ Western Ontario, London, ON, Canada

[16] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA

[17] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA

[18] UT Southwestern Med Ctr, Dallas, TX USA

[19] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA

[20] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA

[21] Harvard Med Sch, Boston, MA 02115 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期

关键词：

D O I：

10.1200/JCO.2019.37.15_suppl.4578

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4578

引用

页数：2

共 50 条

[1] Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma
Bhindi, Bimal
Graham, Jeffrey
Wells, J. Connor
Bakouny, Ziad
Donskov, Frede
Fraccon, Anna
Pasini, Felice
Lee, Jae Lyun
Basappa, Naveen S.
Hansen, Aaron
Kollmannsberger, Christian K.
Kanesvaran, Ravindran
Yuasa, Takeshi
Ernst, D. Scott
Srinivas, Sandy
Rini, Brian, I
Bowman, Isaac
Pal, Sumanta K.
Choueiri, Toni K.
Heng, Daniel Y. C.
EUROPEAN UROLOGY, 2020, 78 (04) : 615 - 623
[2] Newly onset hyperlipidemia in metastatic renal cell carcinoma patients treated with sunitinib.
Baldazzi, Valentina
Tassi, Renato
Lapini, Alberto
Carini, Marco
Mazzanti, Roberto
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
[3] Sunitinib and Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
Bajic, Petar
Flanigan, Robert C.
Joyce, Cara J.
Clark, Joseph I.
JOURNAL OF UROLOGY, 2019, 201 (03): : 453 - 454
[4] Using presurgical sunitinib to select patients with newly diagnosed metastatic clear cell renal cell carcinoma for cytoreductive nephrectomy: A phase II study
Jonasch, Eric
Wood, Christopher G.
Corn, Paul G.
Sharma, Padmanee
Pagliaro, Lance C.
Aparicio, Ana
Do, Kim-Anh
Wang, Xuemei
Marcott, Valerie D.
Matin, Surena F.
Tannir, Nizar M.
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
[5] Therapeutic role of deferred cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
Yoshino, Maki
Ishihara, Hiroki
Nemoto, Yuki
Nakamura, Kazutaka
Nishimura, Koichi
Tachibana, Hidekazu
Fukuda, Hironori
Toki, Daisuke
Yoshida, Kazuhiko
Kobayashi, Hirohito
Iizuka, Junpei
Shimmura, Hiroaki
Hashimoto, Yasunobu
Tanabe, Kazunari
Kondo, Tsunenori
Takagi, Toshio
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (10) : 1208 - 1214
[6] Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy?
Mejean, Arnaud
Ravaud, Alain
Thezenas, Simon
Chevreau, Christine
Bensalah, Karim
Geoffrois, Lionnel
Thiery-Vuillemin, Antoine
Cormier, Luc
Lang, Herve
Guy, Laurent
Gravis, Gwenaelle
Rolland, Frederic
Linassier, Claude
Lechevallier, Eric
Oudard, Stephane
Laguerre, Brigitte
Gross-Goupil, Marine
Bernhard, Jean Christophe
Colas, Sandra
Albiges, Laurence
Lebret, Thierry
Treluyer, Jean-Marc
Timsit, Marc-Olivier
Escudier, Bernard
EUROPEAN UROLOGY, 2021, 80 (04) : 417 - 424
[7] Comprehensive echocardiographic assessment of cardiac function in patients with metastatic renal cell carcinoma newly initiated on sunitinib.
Wang, Le
Narayan, Vivek
Putt, Mary
Keefe, Stephen Michael
Haas, Naomi B.
Lenihan, Daniel John
Puzanov, Igor
Catino, Anna
Fang, James
Ewer, Steven M.
Moncher, Karen
ElAmm, Chantal
Oliveira, Guilherme
Narayan, Hari
Ky, Bonnie
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[8] Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib The SURTIME Randomized Clinical Trial
Bex, Axel
Mulders, Peter
Jewett, Michael
Wagstaff, John
van Thienen, Johannes V.
Blank, Christian U.
van Velthoven, Roland
Laguna, Maria del Pilar
Wood, Lori
van Melick, Harm H. E.
Aarts, Maureen J.
Lattouf, J. B.
Powles, Thomas
de Jong, Igle Jan
Rottey, Sylvie
Tombal, Bertrand
Marreaud, Sandrine
Collette, Sandra
Collette, Laurence
Haanen, John
JAMA ONCOLOGY, 2019, 5 (02) : 164 - 170
[9] Immediate versus deferred cytoreductive nephrectomy (CN) in patients with synchronous metastatic renal cell carcinoma (mRCC) receiving sunitinib (EORTC 30073 SURTIME)
Bex, A.
Mulders, P.
Jewett, M. A. S.
Wagstaff, J.
van Velthoven, R.
Pes, P. M. Laguna
Wood, L.
van Melick, H. H. E.
Soetekouw, P.
Lattouf, J. B.
Powles, T.
Boleti, E.
de Jong, I-J.
Rottey, S.
Tombal, B.
Marreaud, S.
Collette, L.
Collette, S.
Blank, C. U.
Haanen, J. B.
ANNALS OF ONCOLOGY, 2017, 28
[10] Comparison of immediate vs. deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma
Cross, Brian W.
Cookson, Michael S.
JOURNAL OF CANCER METASTASIS AND TREATMENT, 2021, 7

← 1 2 3 4 5 →